Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth

Kimiyasu Egami, Toyoaki Murohara, Toshifumi Shimada, Ken Ichiro Sasaki, Satoshi Shintani, Takeshi Sugaya, Masahiro Ishii, Teiji Akagi, Hisao Ikeda, Toyojiro Matsuishi, Tsutomu Imaizumi

Research output: Contribution to journalArticle

254 Citations (Scopus)

Abstract

Although the renin angiotensin system (RAS) is a major regulator of vascular homeostasis, the role of the RAS in tumor angiogenesis is little understood. Here we show that host angiotensin II (ATII) type 1 (AT1) receptor plays an important role in angiogenesis and growth of tumor cells engrafted in mice. Subcutaneous B16-F1 melanoma-induced angiogenesis as assessed by tissue capillary density and microangiography was prominent in WT mice but was reduced in AT1a receptor-deficient (AT1a-/-) mice. Consequently, tumor growth rate was significantly slower, and the mouse survival rate was greater, in AT1a-/- mice than in WT mice. Tumor growth was also reduced in WT mice treated with TCV-116, a selective blocker of AT1 receptor. Because the β-galactosidase gene was inserted into the AT1a gene locus in AT1a -/- mice, the site of β-galactosidase expression represents the AT1a receptor expression in these mutant mice. In tumor-implanted AT1a -/- mice, the major site of the β-galactosidase expression was macrophages in tissues surrounding tumors. Moreover, the number of infiltrated macrophages was significantly lower in AT1a-/- mice than in WT mice, and double-immunofluorescence staining revealed that these macrophages expressed VEGF protein intensively. Therefore, the host ATII-AT1 receptor pathway supports tumor-associated macrophage infiltration, which results in enhanced tissue VEGF protein levels. The host ATII-AT1 receptor pathway thereby plays important roles in tumor-related angiogenesis and growth in vivo.

Original languageEnglish
Pages (from-to)67-75
Number of pages9
JournalJournal of Clinical Investigation
Volume112
Issue number1
DOIs
Publication statusPublished - Jan 1 2003
Externally publishedYes

Fingerprint

Angiotensin Type 1 Receptor
Growth
Neoplasms
Galactosidases
Macrophages
Renin-Angiotensin System
Vascular Endothelial Growth Factor A
Experimental Melanomas
Genes
Fluorescent Antibody Technique
Blood Vessels
Proteins
Homeostasis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Egami, K., Murohara, T., Shimada, T., Sasaki, K. I., Shintani, S., Sugaya, T., ... Imaizumi, T. (2003). Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. Journal of Clinical Investigation, 112(1), 67-75. https://doi.org/10.1172/JCI16645

Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. / Egami, Kimiyasu; Murohara, Toyoaki; Shimada, Toshifumi; Sasaki, Ken Ichiro; Shintani, Satoshi; Sugaya, Takeshi; Ishii, Masahiro; Akagi, Teiji; Ikeda, Hisao; Matsuishi, Toyojiro; Imaizumi, Tsutomu.

In: Journal of Clinical Investigation, Vol. 112, No. 1, 01.01.2003, p. 67-75.

Research output: Contribution to journalArticle

Egami, K, Murohara, T, Shimada, T, Sasaki, KI, Shintani, S, Sugaya, T, Ishii, M, Akagi, T, Ikeda, H, Matsuishi, T & Imaizumi, T 2003, 'Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth', Journal of Clinical Investigation, vol. 112, no. 1, pp. 67-75. https://doi.org/10.1172/JCI16645
Egami K, Murohara T, Shimada T, Sasaki KI, Shintani S, Sugaya T et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. Journal of Clinical Investigation. 2003 Jan 1;112(1):67-75. https://doi.org/10.1172/JCI16645
Egami, Kimiyasu ; Murohara, Toyoaki ; Shimada, Toshifumi ; Sasaki, Ken Ichiro ; Shintani, Satoshi ; Sugaya, Takeshi ; Ishii, Masahiro ; Akagi, Teiji ; Ikeda, Hisao ; Matsuishi, Toyojiro ; Imaizumi, Tsutomu. / Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. In: Journal of Clinical Investigation. 2003 ; Vol. 112, No. 1. pp. 67-75.
@article{7512e9bf2404454d9acb2ca80bde75ac,
title = "Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth",
abstract = "Although the renin angiotensin system (RAS) is a major regulator of vascular homeostasis, the role of the RAS in tumor angiogenesis is little understood. Here we show that host angiotensin II (ATII) type 1 (AT1) receptor plays an important role in angiogenesis and growth of tumor cells engrafted in mice. Subcutaneous B16-F1 melanoma-induced angiogenesis as assessed by tissue capillary density and microangiography was prominent in WT mice but was reduced in AT1a receptor-deficient (AT1a-/-) mice. Consequently, tumor growth rate was significantly slower, and the mouse survival rate was greater, in AT1a-/- mice than in WT mice. Tumor growth was also reduced in WT mice treated with TCV-116, a selective blocker of AT1 receptor. Because the β-galactosidase gene was inserted into the AT1a gene locus in AT1a -/- mice, the site of β-galactosidase expression represents the AT1a receptor expression in these mutant mice. In tumor-implanted AT1a -/- mice, the major site of the β-galactosidase expression was macrophages in tissues surrounding tumors. Moreover, the number of infiltrated macrophages was significantly lower in AT1a-/- mice than in WT mice, and double-immunofluorescence staining revealed that these macrophages expressed VEGF protein intensively. Therefore, the host ATII-AT1 receptor pathway supports tumor-associated macrophage infiltration, which results in enhanced tissue VEGF protein levels. The host ATII-AT1 receptor pathway thereby plays important roles in tumor-related angiogenesis and growth in vivo.",
author = "Kimiyasu Egami and Toyoaki Murohara and Toshifumi Shimada and Sasaki, {Ken Ichiro} and Satoshi Shintani and Takeshi Sugaya and Masahiro Ishii and Teiji Akagi and Hisao Ikeda and Toyojiro Matsuishi and Tsutomu Imaizumi",
year = "2003",
month = "1",
day = "1",
doi = "10.1172/JCI16645",
language = "English",
volume = "112",
pages = "67--75",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth

AU - Egami, Kimiyasu

AU - Murohara, Toyoaki

AU - Shimada, Toshifumi

AU - Sasaki, Ken Ichiro

AU - Shintani, Satoshi

AU - Sugaya, Takeshi

AU - Ishii, Masahiro

AU - Akagi, Teiji

AU - Ikeda, Hisao

AU - Matsuishi, Toyojiro

AU - Imaizumi, Tsutomu

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Although the renin angiotensin system (RAS) is a major regulator of vascular homeostasis, the role of the RAS in tumor angiogenesis is little understood. Here we show that host angiotensin II (ATII) type 1 (AT1) receptor plays an important role in angiogenesis and growth of tumor cells engrafted in mice. Subcutaneous B16-F1 melanoma-induced angiogenesis as assessed by tissue capillary density and microangiography was prominent in WT mice but was reduced in AT1a receptor-deficient (AT1a-/-) mice. Consequently, tumor growth rate was significantly slower, and the mouse survival rate was greater, in AT1a-/- mice than in WT mice. Tumor growth was also reduced in WT mice treated with TCV-116, a selective blocker of AT1 receptor. Because the β-galactosidase gene was inserted into the AT1a gene locus in AT1a -/- mice, the site of β-galactosidase expression represents the AT1a receptor expression in these mutant mice. In tumor-implanted AT1a -/- mice, the major site of the β-galactosidase expression was macrophages in tissues surrounding tumors. Moreover, the number of infiltrated macrophages was significantly lower in AT1a-/- mice than in WT mice, and double-immunofluorescence staining revealed that these macrophages expressed VEGF protein intensively. Therefore, the host ATII-AT1 receptor pathway supports tumor-associated macrophage infiltration, which results in enhanced tissue VEGF protein levels. The host ATII-AT1 receptor pathway thereby plays important roles in tumor-related angiogenesis and growth in vivo.

AB - Although the renin angiotensin system (RAS) is a major regulator of vascular homeostasis, the role of the RAS in tumor angiogenesis is little understood. Here we show that host angiotensin II (ATII) type 1 (AT1) receptor plays an important role in angiogenesis and growth of tumor cells engrafted in mice. Subcutaneous B16-F1 melanoma-induced angiogenesis as assessed by tissue capillary density and microangiography was prominent in WT mice but was reduced in AT1a receptor-deficient (AT1a-/-) mice. Consequently, tumor growth rate was significantly slower, and the mouse survival rate was greater, in AT1a-/- mice than in WT mice. Tumor growth was also reduced in WT mice treated with TCV-116, a selective blocker of AT1 receptor. Because the β-galactosidase gene was inserted into the AT1a gene locus in AT1a -/- mice, the site of β-galactosidase expression represents the AT1a receptor expression in these mutant mice. In tumor-implanted AT1a -/- mice, the major site of the β-galactosidase expression was macrophages in tissues surrounding tumors. Moreover, the number of infiltrated macrophages was significantly lower in AT1a-/- mice than in WT mice, and double-immunofluorescence staining revealed that these macrophages expressed VEGF protein intensively. Therefore, the host ATII-AT1 receptor pathway supports tumor-associated macrophage infiltration, which results in enhanced tissue VEGF protein levels. The host ATII-AT1 receptor pathway thereby plays important roles in tumor-related angiogenesis and growth in vivo.

UR - http://www.scopus.com/inward/record.url?scp=85047693609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047693609&partnerID=8YFLogxK

U2 - 10.1172/JCI16645

DO - 10.1172/JCI16645

M3 - Article

VL - 112

SP - 67

EP - 75

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -